SS-31 Peptide Investigated for Eye Health Amid Skepticism
The SS-31 peptide, also known as elamipretide, is gaining attention for its potential effects on eye health, particularly age-related macular degeneration (AMD). Despite claims on social media platforms like TikTok that SS-31 can improve eyesight, experts remain skeptical. The peptide is FDA-approved for treating Barth syndrome, a rare mitochondrial disease, but not for vision problems. Research into its effectiveness for AMD is ongoing, with initial studies showing ineffectiveness. Eye doctors emphasize that SS-31 is not a general eyesight improver and does not address common vision issues like astigmatism or presbyopia.